Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

AMRI purchases Gadea Pharmaceutical Group for $174 million

AMRI today announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately-held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product.

16 Jul 2015

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.

15 Jul 2015

Ebola vaccine study begins in Dakar, Senegal

A trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial immunisations started at the Jenner Institute, Oxford University. The announcement comes as a conference in Oxford discusses the global response to Ebola and the implications for future drug and vaccine development.

15 Jul 2015

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

The spectrum of patients seen today, from pre-term infants to the morbidly obese to the longer living elderly, is wider than ever before and increasingly more challenging with patients often presenting with multiple co-morbidities. This puts a huge strain on healthcare providers who are facing increasing challenges such as cost pressure and staff shortages.

14 Jul 2015

Quotient Clinical acquires second GMP manufacturing facility, expands pharmaceutical sciences capabilities

Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.

14 Jul 2015

ANI acquires 22 previously marketed generic drug products for $25 million from Teva Pharmaceuticals

ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.

13 Jul 2015

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Tillotts Pharma AG, part of the Zeria Group, announced today that it has entered into an agreement for the acquisition of the global rights for Entocort (budesonide) from AstraZeneca, excluding the U.S., which will remain with AstraZeneca.

9 Jul 2015

Vanderbilt investigators develop potential antibody treatments against chikungunya

In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.

9 Jul 2015

Chemicals used in plastics linked to increased risk of high blood pressure, diabetes in children and adolescents

According to a new series of studies out of NYU Langone Medical Center, two chemicals increasingly used during manufacturing to strengthen plastic wrap, soap, cosmetics, and processed food containers have been linked to a rise in risk of high blood pressure and diabetes in children and adolescents.

9 Jul 2015

Hi-Tech enters into definitive agreement to acquire Innovative's brand of Diet Aids

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition, Weight loss products, and Contract Manufacturing services, and Innovative laboratories, one of the fastest-growing Weight Loss brands in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire Innovative's brand of Diet Aids.

7 Jul 2015

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).

7 Jul 2015

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

More than 5,500 sociologists will convene in Chicago this August to explore ideas and scientific research relating to sexuality and many other topics, as part of the American Sociological Association's 110th Annual Meeting. This year's theme, "Sexualities in the Social World," shows the importance of research by sociologists in illuminating how social norms and social inequalities affect what sexual behavior is acceptable and who partners with whom.

7 Jul 2015

Zecotek provides shareholders with corporate update on 3D display and 3D printing technologies

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge 3D display and 3D printing technologies.

6 Jul 2015

Konica Minolta announces acquisition of Sawae Technologica

Konica Minolta, Inc. today announced that it has acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer based in Minas Gerais, Brazil, through its Brazilian healthcare sales company, Konica Minolta Healthcare do Brazil.

2 Jul 2015

Strong Precision Technologies' two medical divisions now going to market under MedTorque brand

Strong Precision Technologies announced today that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI.

2 Jul 2015

Spectrum Health Innovations inks licensing agreement with Min-Bio to manufacture trauma surgery basin

Spectrum Health Innovations has signed a licensing agreement with Min-Bio, LLC, of Lowell, Mich. to manufacture a new trauma surgery basin that is a cut above existing designs.

2 Jul 2015

ExeGi Pharma granted product license to sell Visbiome formulation in Canada

ExeGi Pharma, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has been granted a product license by the Health Canada Natural and Non-prescription Health Products Directorate (NNHPD) to sell Visbiome in Canada.

1 Jul 2015

Nuclea and Aelan partner to develop, commercialize novel biomarker tests using STEM cells as models

Nuclea Biotechnologies Inc. announced today that it is partnering with Aelan Cell Technologies Inc. (San Francisco, California) for the development, validation and commercialization of novel biomarker tests and companion diagnostics using human STEM cells as models.

1 Jul 2015

R-Japan receives license for cell processing facility

R-Japan Co.,Ltd. obtained the license of cell processing facility under the Act on the Safety of Regenerative Medicine from the Ministry of Health, Labour and Welfare Kinki Bureau of Health and Welfare on June 29, 2015.

1 Jul 2015

Telesta submits Biologics License Application for MCNA to FDA

Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.

30 Jun 2015

Manufacturing News and Research

Further Reading

AMRI purchases Gadea Pharmaceutical Group for $174 million

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

Ebola vaccine study begins in Dakar, Senegal

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

Quotient Clinical acquires second GMP manufacturing facility, expands pharmaceutical sciences capabilities

ANI acquires 22 previously marketed generic drug products for $25 million from Teva Pharmaceuticals

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Vanderbilt investigators develop potential antibody treatments against chikungunya

Chemicals used in plastics linked to increased risk of high blood pressure, diabetes in children and adolescents

Hi-Tech enters into definitive agreement to acquire Innovative's brand of Diet Aids

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

Zecotek provides shareholders with corporate update on 3D display and 3D printing technologies

Konica Minolta announces acquisition of Sawae Technologica

Strong Precision Technologies' two medical divisions now going to market under MedTorque brand

Spectrum Health Innovations inks licensing agreement with Min-Bio to manufacture trauma surgery basin

ExeGi Pharma granted product license to sell Visbiome formulation in Canada

Nuclea and Aelan partner to develop, commercialize novel biomarker tests using STEM cells as models

R-Japan receives license for cell processing facility

Telesta submits Biologics License Application for MCNA to FDA

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®